Surrogacy of time to prgression for overall survival in advanced hepatocellular carcinoma treated with systemic therapy: A systematic review and meta-analysis of randomized controlled trials.

被引：0
|
作者：
Terashima, Takeshi [1 ]
Yamashita, Tatsuya [1 ]
Arai, Kuniaki [1 ]
Toyama, Tadashi [1 ]
Kawaguchi, Kazunori [1 ]
Kitamura, Kazuya [1 ]
Yamashita, Taro [1 ]
Sakai, Yoshio [1 ]
Mizukoshi, Eishiro [1 ]
Honda, Masao [1 ]
Kaneko, Shuichi [1 ]
机构：
[1] Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 04期
关键词：
D O I：
10.1200/JCO.2018.36.4_suppl.403
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
403
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Surrogacy of Time to Progression for Overall Survival in Advanced Hepatocellular Carcinoma Treated with Systemic Therapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Terashima, Takeshi
    Yamashita, Tatsuya
    Toyama, Tadashi
    Arai, Kuniaki
    Kawaguchi, Kazunori
    Kitamura, Kazuya
    Yamashita, Taro
    Sakai, Yoshio
    Mizukoshi, Eishiro
    Honda, Masao
    Kaneko, Shuichi
    LIVER CANCER, 2019, 8 (02) : 130 - 139
  • [2] Comparison of systemic therapy efficacy in advanced hepatocellular carcinoma: Systematic review and frequentist network meta-analysis of randomized controlled trials.
    Park, Robin
    da Silva, Laercio Lopes
    Nissaisorakarn, Voravech
    Riano, Ivy
    Saeed, Anwaar
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [3] OBJECTIVE RESPONSE BY MRECIST IS A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL IN UNRESECTABLE HEPATOCELLULAR CARCINOMA TREATED WITH SYSTEMIC THERAPY: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Kudo, Masatoshi
    Ueshima, Kazuomi
    Nishida, Naoshi
    HEPATOLOGY, 2019, 70 : 221A - 221A
  • [4] Surrogate endpoint in advanced hepatocellular carcinoma treated with molecular targeted therapy: Meta-analysis of randomized controlled trials.
    Lee, Kyung-Hun
    Lee, Dae-Won
    Jang, Myoung-Jin
    Kim, Tae-Yong
    Han, Sae-Won
    Oh, Do-Youn
    Im, Seock-Ah
    Kim, Tae-You
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Association of objective response by mRECIST with better overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with systemic therapies: A systematic review and meta-analysis of randomized controlled trials
    Kudo, Masatoshi
    Chiba, Yasutaka
    Meyer, Tim
    Lencioni, Riccardo
    Llovet, Josep M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [6] COMPARISON OF FIRSTLINE SYSTEMIC THERAPIES FOR ADVANCED HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Hur, Moon Haeng
    Park, Youngsu
    Ko, Yunmi
    Shin, Hyunjae
    Park, Jeayeon
    Kim, Ju Yeon
    Lee, Yun Bin
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Jeong-Hoon
    HEPATOLOGY, 2023, 78 : S1821 - S1821
  • [7] Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials
    Ji, Xi-Qing
    Ruan, Xin-Jian
    Chen, Hong
    Chen, Gang
    Li, Shi-Yong
    Yu, Bo
    MEDICAL SCIENCE MONITOR, 2011, 17 (08): : RA169 - RA176
  • [8] Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials
    Park, Robin
    da Silva, Laercio Lopes
    Nissaisorakarn, Voravech
    Riano, Ivy
    Williamson, Stephen
    Sun, Weijing
    Saeed, Anwaar
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2021, 8 : 145 - 154
  • [9] Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Guo, Tian-Kang
    Hao, Xiang-Yong
    Ma, Bin
    Yang, Ke-Hu
    Li, Yi-Ping
    Li, Hong-Ling
    Gu, Yuan-Hui
    Cai, Hui
    Liu, Ya-Li
    Li, Yuan
    Zhan, Wei-Peng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (12) : 1685 - 1692
  • [10] Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials
    Tian-Kang Guo
    Xiang-Yong Hao
    Bin Ma
    Ke-Hu Yang
    Yi-Ping Li
    Hong-Ling Li
    Yuan-Hui Gu
    Hui Cai
    Ya-Li Liu
    Yuan Li
    Wei-Peng Zhan
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1685 - 1692
12345